PE20040623A1 - Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa - Google Patents

Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa

Info

Publication number
PE20040623A1
PE20040623A1 PE2003000527A PE2003000527A PE20040623A1 PE 20040623 A1 PE20040623 A1 PE 20040623A1 PE 2003000527 A PE2003000527 A PE 2003000527A PE 2003000527 A PE2003000527 A PE 2003000527A PE 20040623 A1 PE20040623 A1 PE 20040623A1
Authority
PE
Peru
Prior art keywords
combination
acetylcholine esterase
nmda antagonist
esterase inhibitors
inhibitors
Prior art date
Application number
PE2003000527A
Other languages
English (en)
Spanish (es)
Inventor
Lars Lykke Thomsen
Anders Gersel Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28051666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20040623(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PE20040623A1 publication Critical patent/PE20040623A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2003000527A 2002-05-31 2003-05-29 Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa PE20040623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200844 2002-05-31

Publications (1)

Publication Number Publication Date
PE20040623A1 true PE20040623A1 (es) 2004-09-11

Family

ID=28051666

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000527A PE20040623A1 (es) 2002-05-31 2003-05-29 Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa

Country Status (9)

Country Link
KR (1) KR101016927B1 (is)
CN (1) CN1655793A (is)
AR (1) AR040121A1 (is)
CA (1) CA2426492C (is)
EA (1) EA007632B1 (is)
IS (1) IS7558A (is)
PE (1) PE20040623A1 (is)
UA (1) UA82480C2 (is)
ZA (1) ZA200409147B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
CN105294450B (zh) * 2014-05-29 2024-05-17 广州喜鹊医药有限公司 具有神经保护作用的金刚烷胺硝酸酯化合物及其制备和医药应用
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR20210072569A (ko) 2019-12-09 2021-06-17 주식회사 종근당 도네페질 및 메만틴을 포함하는 복합 제제

Also Published As

Publication number Publication date
AR040121A1 (es) 2005-03-16
EA007632B1 (ru) 2006-12-29
CA2426492A1 (en) 2003-09-16
UA82480C2 (uk) 2008-04-25
KR101016927B1 (ko) 2011-02-28
EA200401617A1 (ru) 2005-06-30
IS7558A (is) 2004-11-26
KR20050024296A (ko) 2005-03-10
ZA200409147B (en) 2006-06-28
CN1655793A (zh) 2005-08-17
CA2426492C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
TR200102647T2 (tr) Doğurganlığı geliştirmeye mahsus bileşimler
CL2010001160A1 (es) Compuestos derivados de 3,8-diazabiciclo[4.2.0]octano y 3,6-diazabiciclo[3.2.0]heptano; composicion farmaceutica; moduladores del reeptor de la orexina, utiles en el tratamiento del insomnio.
UY26482A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
AR037771A1 (es) Moleculas pequenas para el tratamiento del crecimiento celular anormal
CO4560552A1 (es) Antagonistas de receptores de taquicininas no peptidicos
CL2008003593A1 (es) Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DOP2002000438A (es) Inhibidores de la dipetidil peptidasa beta-amino heterocíclica para el tratamiento o la prevención de la diabetes
CL2007002492A1 (es) Compuestos derivados de bi-,tri o policiclos no aromaticos, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; proceso de preparacion de estos; composicion famaceutica que los comprende; uso en el tratamiento de enfermedades tales como la obesidad, diabetes y dislipidemia, entre otras.
CL2008000899A1 (es) Compuestos derivados de 3-imidazolil-indolilo, inhibidores de la interaccion entre p53 y mdm2 y/o mdm4; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento y/o profilaxis de enfermedades proliferativas.
BRPI0513317A (pt) ciclosporinas para tratar doença de alzheimer
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
PE20110431A1 (es) Etexilato de dabigatran o una sal del mismo
AR052071A1 (es) Procedimientos para modular las actividades del receptor nicotinico alfa 7 de acetilcolina
CL2010001123A1 (es) Uso de piridin-3-ilmetil docosahexanoato para preparar un medicamento util para la prevencion y/o el tratamiento de enfermedades cardiovasculares (divisional solicitud 1848-07).
NI200700292A (es) Amidas novedosas derivadas de acidos piperidin carboxilicos
CL2007003190A1 (es) Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras.
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
AR056971A1 (es) COMPOSICIONES AZEOTRoPICAS QUE COMPRENDEN 1,1,3,3,3-PENTAFLUOROPROPENO Y FLUORURO DE HIDRoGENO Y USOS DE LAS MISMAS
GB0216001D0 (en) Process and composition
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
DE60101213D1 (de) Pharmazeutische zusammensetzung enthaltend einen squalenepoxidasehemmer und einen makrolid-immunomodulator
PE20040623A1 (es) Combinacion de antagonista de nmda con inhibidores de la acetilcolina esterasa
AR029155A1 (es) Combinacion y uso de la misma en la fabricacion de un medicamento util para tratar afecciones cardiovasculares

Legal Events

Date Code Title Description
FC Refusal